Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 308

1.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P.

Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Review.

2.

Recommended configuration for personal health records by standardized data item sets for diabetes mellitus and associated chronic diseases: a report from a collaborative initiative by six Japanese associations.

Nakashima N, Noda M, Ueki K, Koga T, Hayashi M, Yamazaki K, Nakagami T, Ohara M, Gochi A, Matsumura Y, Kimura M, Ohe K, Kang D, Toya Y, Yamagata K, Yokote K, Ikeda S, Mitsutake N, Yamamoto R, Tanizawa Y.

Diabetol Int. 2019 Apr 25;10(2):85-92. doi: 10.1007/s13340-019-00389-7. eCollection 2019 Apr.

PMID:
31139526
3.

Recommended configuration for personal health records by standardized data item sets for diabetes mellitus and associated chronic diseases: A report from Collaborative Initiative by six Japanese Associations.

Nakashima N, Noda M, Ueki K, Koga T, Hayashi M, Yamazaki K, Nakagami T, Ohara M, Gochi A, Matsumura Y, Kimura M, Ohe K, Kang D, Toya Y, Yamagata K, Yokote K, Ikeda S, Mitsutake N, Yamamoto R, Tanizawa Y.

J Diabetes Investig. 2019 May;10(3):868-875. doi: 10.1111/jdi.13043. Epub 2019 Apr 25.

4.

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).

Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, Nakamura S, Yamaga M, Yokoh H, Kobayashi A, Onishi S, Kobayashi K, Ogino J, Hashimoto N, Tokuyama H, Shimada F, Ohara E, Ishikawa T, Shoji M, Ide S, Ide K, Baba Y, Hattori A, Kitamoto T, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Takemoto M, Newby LK, Yokote K; PRIME-V Study Group.

Diabetes Obes Metab. 2019 Aug;21(8):1990-1995. doi: 10.1111/dom.13750. Epub 2019 May 8.

PMID:
30993861
5.

CXCL12-CXCR4 pathway activates brown adipocytes and induces insulin resistance in CXCR4-deficient mice under high-fat diet.

Kurita K, Ishikawa K, Takeda K, Fujimoto M, Ono H, Kumagai J, Inoue H, Yokoh H, Yokote K.

Sci Rep. 2019 Apr 16;9(1):6165. doi: 10.1038/s41598-019-42127-8.

6.

Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.

Kato H, Senoh M, Honda H, Fukuda T, Tagashira Y, Horiuchi H, Chiba H, Suzuki D, Hosokawa N, Kitazono H, Norisue Y, Kume H, Mori N, Morikawa H, Kashiwagura S, Higuchi A, Kato H, Nakamura M, Ishiguro S, Morita S, Ishikawa H, Watanabe T, Kojima K, Yokomaku I, Bando T, Toimoto K, Moriya K, Kasahara K, Kitada S, Ogawa J, Saito H, Tominaga H, Shimizu Y, Masumoto F, Tadera K, Yoshida J, Kikuchi T, Yoshikawa I, Watanabe T, Honda M, Yokote K, Toyokawa T, Miyazato H, Nakama M, Mahe C, Reske K, Olsen MA, Dubberke ER.

Anaerobe. 2019 Mar 12. pii: S1075-9964(19)30046-0. doi: 10.1016/j.anaerobe.2019.03.007. [Epub ahead of print]

PMID:
30872073
7.

Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52-week data from the PROVIDE study.

Araki E, Yamashita S, Arai H, Yokote K, Satoh J, Inoguchi T, Nakamura J, Maegawa H, Yoshioka N, Tanizawa Y, Watada H, Suganami H, Ishibashi S.

Diabetes Obes Metab. 2019 Jul;21(7):1737-1744. doi: 10.1111/dom.13686. Epub 2019 Apr 1.

8.

Syringaresinol Reverses Age-Related Skin Atrophy by Suppressing FoxO3a-Mediated Matrix Metalloproteinase-2 Activation in Copper/Zinc Superoxide Dismutase-Deficient Mice.

Kim J, Toda T, Watanabe K, Shibuya S, Ozawa Y, Izuo N, Cho S, Seo DB, Yokote K, Shimizu T.

J Invest Dermatol. 2019 Mar;139(3):648-655. doi: 10.1016/j.jid.2018.10.012. Epub 2018 Oct 26.

PMID:
30798853
9.

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment.

Yokote K, Yamashita S, Arai H, Araki E, Suganami H, Ishibashi S, Of The K-Study Group OB.

Int J Mol Sci. 2019 Feb 6;20(3). pii: E706. doi: 10.3390/ijms20030706.

10.

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M.

Diabetes Care. 2019 Jun;42(6):1147-1154. doi: 10.2337/dc18-2316. Epub 2019 Feb 6. Review.

PMID:
30728224
11.

Systemic oscillator-driven and nutrient-responsive hormonal regulation of daily expression rhythms for gluconeogenic enzyme genes in the mouse liver.

Taira A, Arita E, Matsumoto E, Oohira A, Iwase K, Hiwasa T, Yokote K, Shibata S, Takiguchi M.

Chronobiol Int. 2019 May;36(5):591-615. doi: 10.1080/07420528.2019.1570246. Epub 2019 Feb 3.

PMID:
30714432
12.

Genetic and transcriptional landscape of plasma cells in POEMS syndrome.

Nagao Y, Mimura N, Takeda J, Yoshida K, Shiozawa Y, Oshima M, Aoyama K, Saraya A, Koide S, Rizq O, Hasegawa Y, Shiraishi Y, Chiba K, Tanaka H, Nishijima D, Isshiki Y, Kayamori K, Kawajiri-Manako C, Oshima-Hasegawa N, Tsukamoto S, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Iseki T, Misawa S, Miyano S, Ohara O, Yokote K, Sakaida E, Kuwabara S, Sanada M, Iwama A, Ogawa S, Nakaseko C.

Leukemia. 2019 Jul;33(7):1723-1735. doi: 10.1038/s41375-018-0348-x. Epub 2019 Jan 11.

PMID:
30635632
13.

Characteristic Clinical Features of Werner Syndrome with a Novel Compound Heterozygous WRN Mutation c.1720+1G>A Plus c.3139-1G>C.

Matsumoto N, Ohta Y, Deguchi K, Kishida M, Sato K, Shang J, Takemoto M, Hishikawa N, Yamashita T, Watanabe A, Yokote K, Takemoto M, Oshima J, Abe K.

Intern Med. 2019 Apr 1;58(7):1033-1036. doi: 10.2169/internalmedicine.1816-18. Epub 2018 Dec 18.

14.

Ceritinib Aggravates Glycemic Control in Insulin-treated Patients with Diabetes and Metastatic ALK-positive Lung Cancer.

Sakuma I, Nagano H, Yoshino I, Yokote K, Tanaka T.

Intern Med. 2019 Mar 15;58(6):817-820. doi: 10.2169/internalmedicine.1870-18. Epub 2018 Nov 19.

15.

Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Obes Metab. 2018 Nov 4. doi: 10.1111/dom.13575. [Epub ahead of print]

16.

Transcription Factor 21 Is Required for Branching Morphogenesis and Regulates the Gdnf-Axis in Kidney Development.

Ide S, Finer G, Maezawa Y, Onay T, Souma T, Scott R, Ide K, Akimoto Y, Li C, Ye M, Zhao X, Baba Y, Minamizuka T, Jin J, Takemoto M, Yokote K, Quaggin SE.

J Am Soc Nephrol. 2018 Dec;29(12):2795-2808. doi: 10.1681/ASN.2017121278. Epub 2018 Oct 30.

PMID:
30377232
17.

Human glomerular transcriptome of diabetic kidneys: Can the podocyte cytoskeleton be a therapeutic target?

Maezawa Y, Yokote K.

J Diabetes Investig. 2019 Mar;10(2):224-226. doi: 10.1111/jdi.12951. Epub 2018 Nov 8. No abstract available.

18.

Apheresis on aged patients/donors with complicated backgrounds like ischemic heart disease, arrhythmia, and others.

Yokohama A, Yokote K, Maruhashi T.

Transfus Apher Sci. 2018 Oct;57(5):619-622. doi: 10.1016/j.transci.2018.09.006. Epub 2018 Sep 18. Review.

PMID:
30262215
19.

Development of the Dementia Assessment Sheet for Community-based Integrated Care System 8-items, a short version of the Dementia Assessment Sheet for Community-based Integrated Care System 21-items, for the assessment of cognitive and daily functions.

Toyoshima K, Araki A, Tamura Y, Iritani O, Ogawa S, Kozaki K, Ebihara S, Hanyu H, Arai H, Kuzuya M, Iijima K, Sakurai T, Suzuki T, Toba K, Arai H, Akishita M, Rakugi H, Yokote K, Ito H, Awata S.

Geriatr Gerontol Int. 2018 Oct;18(10):1458-1462. doi: 10.1111/ggi.13512. Epub 2018 Sep 17.

PMID:
30225857
20.

Biallelic WRN Mutations in Newly Identified Japanese Werner Syndrome Patients.

Maezawa Y, Kato H, Takemoto M, Watanabe A, Koshizaka M, Ishikawa T, Sargolzaeiaval F, Kuzuya M, Wakabayashi H, Kusaka T, Yokote K, Oshima J.

Mol Syndromol. 2018 Jul;9(4):214-218. doi: 10.1159/000489055. Epub 2018 May 15.

21.

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S; Committee for Epidemiology and Clinical Management of Atherosclerosis.

J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22. No abstract available.

22.

Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia.

Yamashita S, Arai H, Yokote K, Araki E, Suganami H, Ishibashi S; K-877 Study Group.

J Clin Lipidol. 2018 Sep - Oct;12(5):1267-1279.e4. doi: 10.1016/j.jacl.2018.06.010. Epub 2018 Jun 26.

23.

p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells.

Nagano H, Hashimoto N, Nakayama A, Suzuki S, Miyabayashi Y, Yamato A, Higuchi S, Fujimoto M, Sakuma I, Beppu M, Yokoyama M, Suzuki Y, Sugano S, Ikeda K, Tatsuno I, Manabe I, Yokote K, Inoue S, Tanaka T.

Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8370-8375. doi: 10.1073/pnas.1804243115. Epub 2018 Jul 30.

24.

Clonal immunoglobulin λ light-chain gene rearrangements detected by next generation sequencing in POEMS syndrome.

Kawajiri-Manako C, Mimura N, Fukuyo M, Namba H, Rahmutulla B, Nagao Y, Togasaki E, Shimizu R, Oshima-Hasegawa N, Tsukamoto S, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Iseki T, Misawa S, Yokote K, Tsuiji M, Kuwabara S, Sakaida E, Kaneda A, Nakaseko C.

Am J Hematol. 2018 Sep;93(9):1161-1168. doi: 10.1002/ajh.25213. Epub 2018 Aug 31.

PMID:
30015379
25.

Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review.

Ishibashi R, Takemoto M, Tsurutani Y, Kuroda M, Ogawa M, Wakabayashi H, Uesugi N, Nagata M, Imai N, Hattori A, Sakamoto K, Kitamoto T, Maezawa Y, Narita I, Hiroi S, Furuta A, Miida T, Yokote K.

J Clin Lipidol. 2018 Jul - Aug;12(4):888-897.e2. doi: 10.1016/j.jacl.2018.05.002. Epub 2018 May 15.

PMID:
29937398
26.

Evaluation of a high serum docosahexaenoic acid level as a predictor of longevity among elderly residents at a special nursing home.

Matsuda H, Matsuda M, Koshizaka M, Matsuda Y, Sakamoto K, Yokote K, Matsuda Y, Takemoto M.

Geriatr Gerontol Int. 2018 Jun;18(6):980-982. doi: 10.1111/ggi.13297. No abstract available.

PMID:
29924493
27.

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.

Harada-Shiba M, Arai H, Ishigaki Y, Ishibashi S, Okamura T, Ogura M, Dobashi K, Nohara A, Bujo H, Miyauchi K, Yamashita S, Yokote K; Working Group by Japan Atherosclerosis Society for Making Guidance of Familial Hypercholesterolemia.

J Atheroscler Thromb. 2018 Aug 1;25(8):751-770. doi: 10.5551/jat.CR003. Epub 2018 Jun 7.

28.

RECQ helicase disease and related progeroid syndromes: RECQ2018 meeting.

Oshima J, Kato H, Maezawa Y, Yokote K.

Mech Ageing Dev. 2018 Jul;173:80-83. doi: 10.1016/j.mad.2018.05.002. Epub 2018 May 9. Review.

29.

Apple procyanidins promote mitochondrial biogenesis and proteoglycan biosynthesis in chondrocytes.

Masuda I, Koike M, Nakashima S, Mizutani Y, Ozawa Y, Watanabe K, Sawada Y, Sugiyama H, Sugimoto A, Nojiri H, Sashihara K, Yokote K, Shimizu T.

Sci Rep. 2018 May 8;8(1):7229. doi: 10.1038/s41598-018-25348-1.

30.

Glucagonoma With Necrolytic Migratory Erythema: Metabolic Profile and Detection of Biallelic Inactivation of DAXX Gene.

Tamura A, Ogasawara T, Fujii Y, Kaneko H, Nakayama A, Higuchi S, Hashimoto N, Miyabayashi Y, Fujimoto M, Komai E, Kono T, Sakuma I, Nagano H, Suzuki S, Koide H, Yokote K, Iseki K, Oguma R, Matsue H, Nojima H, Sugiura K, Yoshitomi H, Ohtsuka M, Rahmutulla B, Kaneda A, Inoshita N, Ogawa S, Tanaka T.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2417-2423. doi: 10.1210/jc.2017-02646.

PMID:
29688432
31.

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial.

Arai H, Yamashita S, Yokote K, Araki E, Suganami H, Ishibashi S; K-877 Study Group.

J Atheroscler Thromb. 2018 Jun 1;25(6):521-538. doi: 10.5551/jat.44412. Epub 2018 Apr 7.

32.

Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain.

Watanabe K, Hirano S, Kojima K, Nagashima K, Mukai H, Sato T, Takemoto M, Matsumoto K, Iimori T, Isose S, Omori S, Shibuya K, Sekiguchi Y, Beppu M, Amino H, Suichi T, Yokote K, Uno T, Kuwabara S, Misawa S.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1082-1087. doi: 10.1136/jnnp-2017-316601. Epub 2018 Apr 7.

PMID:
29627772
33.

Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Care. 2018 Jun;41(6):1275-1284. doi: 10.2337/dc17-2224. Epub 2018 Apr 6.

PMID:
29626074
34.

Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance.

Matsuba I, Matsuba R, Ishibashi S, Yamashita S, Arai H, Yokote K, Suganami H, Araki E.

J Diabetes Investig. 2018 Nov;9(6):1323-1332. doi: 10.1111/jdi.12845. Epub 2018 Apr 26.

35.

Postpartum risk of diabetes and predictive factors for glucose intolerance in East Asian women with gestational diabetes.

Inoue H, Ishikawa K, Takeda K, Kobayashi A, Kurita K, Kumagai J, Yokoh H, Yokote K.

Diabetes Res Clin Pract. 2018 Jun;140:1-8. doi: 10.1016/j.diabres.2018.03.031. Epub 2018 Mar 26.

36.

N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.

Ide K, Koshizaka M, Tokuyama H, Tokuyama T, Ishikawa T, Maezawa Y, Takemoto M, Yokote K.

Lipids Health Dis. 2018 Mar 15;17(1):51. doi: 10.1186/s12944-018-0706-8.

37.

Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.

Yoshida Y, Wang H, Hiwasa T, Machida T, Kobayashi E, Mine S, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Takizawa H, Kashiwado K, Kamitsukasa I, Shin H, Wada T, Aotsuka A, Nishi E, Ohno M, Takemoto M, Yokote K, Takahashi S, Matsushima J, Zhang XM, Takiguchi M, Iwadate Y.

Oncotarget. 2017 Dec 24;9(10):8836-8848. doi: 10.18632/oncotarget.23653. eCollection 2018 Feb 6.

38.

A Novel Approach to the Treatment of Plasma Protein Deficiency: Ex Vivo-Manipulated Adipocytes for Sustained Secretion of Therapeutic Proteins.

Kuroda M, Saito Y, Aso M, Yokote K.

Chem Pharm Bull (Tokyo). 2018;66(3):217-224. doi: 10.1248/cpb.c17-00786. Review.

39.

Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.

Wang H, Zhang XM, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Kimura R, Mine S, Kamitsukasa I, Wada T, Aotsuka A, Yoshida Y, Kobayashi E, Matsutani T, Iwadate Y, Sugimoto K, Mori M, Uzawa A, Muto M, Kuwabara S, Takemoto M, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Ohno M, Chen PM, Nishi E, Ono K, Kimura T, Machida T, Takizawa H, Kashiwado K, Shimada H, Ito M, Goto KI, Iwase K, Ashino H, Taira A, Arita E, Takiguchi M, Hiwasa T.

Oncotarget. 2017 Dec 31;9(5):5600-5613. doi: 10.18632/oncotarget.23789. eCollection 2018 Jan 19.

40.

Physician-initiated clinical study of limb ulcers treated with a functional peptide, SR-0379: from discovery to a randomized, double-blind, placebo-controlled trial.

Nakagami H, Sugimoto K, Ishikawa T, Fujimoto T, Yamaoka T, Hayashi M, Kiyohara E, Ando H, Terabe Y, Takami Y, Yamamoto K, Takeya Y, Takemoto M, Koshizaka M, Ebihara T, Nakamura A, Nishikawa M, Yao XJ, Hanaoka H, Katayama I, Yokote K, Rakugi H.

NPJ Aging Mech Dis. 2018 Feb 13;4:2. doi: 10.1038/s41514-018-0021-7. eCollection 2018.

41.

Guidance for Pediatric Familial Hypercholesterolemia 2017.

Harada-Shiba M, Ohta T, Ohtake A, Ogura M, Dobashi K, Nohara A, Yamashita S, Yokote K; Joint Working Group by Japan Pediatric Society and Japan Atherosclerosis Society for Making Guidance of Pediatric Familial Hypercholesterolemia.

J Atheroscler Thromb. 2018 Jun 1;25(6):539-553. doi: 10.5551/jat.CR002. Epub 2018 Feb 6.

42.

Serum podocalyxin levels correlate with carotid intima media thickness, implicating its role as a novel biomarker for atherosclerosis.

Shoji M, Takemoto M, Kobayashi K, Shoji T, Mori S, Sagara JI, Kurosawa H, Hirayama Y, Sakamoto K, Ishikawa T, Koshizaka M, Maezawa Y, Yokote K.

Sci Rep. 2018 Jan 10;8(1):245. doi: 10.1038/s41598-017-18647-6.

43.

Distinct roles of systemic and local actions of insulin on pancreatic β-cells.

Kitamoto T, Sakurai K, Lee EY, Yokote K, Accili D, Miki T.

Metabolism. 2018 May;82:100-110. doi: 10.1016/j.metabol.2017.12.017. Epub 2018 Jan 7.

PMID:
29320716
44.

Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial.

Araki E, Yamashita S, Arai H, Yokote K, Satoh J, Inoguchi T, Nakamura J, Maegawa H, Yoshioka N, Tanizawa Y, Watada H, Suganami H, Ishibashi S.

Diabetes Care. 2018 Mar;41(3):538-546. doi: 10.2337/dc17-1589. Epub 2018 Jan 3.

PMID:
29298800
45.

Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial.

Ishibashi S, Arai H, Yokote K, Araki E, Suganami H, Yamashita S; K-877 Study Group.

J Clin Lipidol. 2018 Jan - Feb;12(1):173-184. doi: 10.1016/j.jacl.2017.10.006. Epub 2017 Oct 28.

46.

Prednisolone-responsive Postpartum IgG4-related Hypophysitis.

Koide H, Shiga A, Komai E, Yamato A, Fujimoto M, Tamura A, Kono T, Nakayama A, Takiguchi T, Higuchi S, Sakuma I, Nagano H, Hashimoto N, Suzuki S, Takeda Y, Shibuya M, Nishioka H, Yamada S, Inoshita N, Ishiwatari N, Horiguchi K, Yokote K, Tanaka T.

Intern Med. 2018 Feb 1;57(3):367-375. doi: 10.2169/internalmedicine.8446-16. Epub 2017 Nov 1.

47.

A Toxic Conformer of Aβ42 with a Turn at 22-23 is a Novel Therapeutic Target for Alzheimer's Disease.

Izuo N, Kasahara C, Murakami K, Kume T, Maeda M, Irie K, Yokote K, Shimizu T.

Sci Rep. 2017 Sep 18;7(1):11811. doi: 10.1038/s41598-017-11671-6.

48.

Case of lipoatrophic diabetes induced by juvenile dermatomyositis.

Baba Y, Kaneko H, Takemoto M, Ide K, Haga Y, Kanda T, Akita S, Kubota Y, Kuroda M, Kitagawa Y, Yokote K.

J Diabetes Investig. 2017 Sep 12. doi: 10.1111/jdi.12745. [Epub ahead of print]

49.

The clinical characteristics of Asian patients with classical-type Hutchinson-Gilford progeria syndrome.

Sato-Kawano N, Takemoto M, Okabe E, Yokote K, Matsuo M, Kosaki R, Ihara K.

J Hum Genet. 2017 Dec;62(12):1031-1035. doi: 10.1038/jhg.2017.90. Epub 2017 Sep 7.

PMID:
28878338
50.

Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.

Takiguchi T, Koide H, Nagano H, Nakayama A, Fujimoto M, Tamura A, Komai E, Shiga A, Kono T, Higuchi S, Sakuma I, Hashimoto N, Suzuki S, Miyabayashi Y, Ishiwatari N, Horiguchi K, Nakatani Y, Yokote K, Tanaka T.

BMC Endocr Disord. 2017 Sep 2;17(1):54. doi: 10.1186/s12902-017-0203-5.

Supplemental Content

Loading ...
Support Center